Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder.

Source:http://linkedlifedata.com/resource/pubmed/id/2274626

Download in:

View as

General Info

PMID
2274626